Skip to main content

Institutional intelligence for Strides Pharma Science Limited

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Tracked super investors holding ≥1%

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters27.91%
  • FII28.39%
  • Mutual Funds8.73%
  • DII (ex-MF)6.68%
  • Retail & others28.29%
  • Super Investors 1.12%(subset)
  • 1% Club 10.37%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

FII / FPI

Foreign portfolio investors

28.39%4 named
HolderStakeSharesValue (₹ Cr)
5.05%46,53,310₹509.1 Cr
2.17%19,97,344₹218.5 Cr
1.33%12,25,663₹134.1 Cr
1.05%9,72,207₹106.4 Cr

Promoters

Promoter & promoter group

27.91%4 named
HolderStakeSharesValue (₹ Cr)
19.62%1,80,84,585₹1.98k Cr
3.50%32,25,050₹352.9 Cr
2.02%18,60,687₹203.6 Cr
1.36%12,55,593₹137.4 Cr

Retail & others

Holders below 1% disclosure threshold and public non-institutions

28.29%

SEBI requires naming only shareholders with ≥1% stake. The remaining 28.29% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

10.37%5 named
HolderStakeSharesValue (₹ Cr)
4.76%43,87,939₹480.1 Cr
1.63%15,02,309₹164.4 Cr
1.60%14,74,942₹161.4 Cr
1.28%11,75,622₹128.6 Cr
1.10%10,11,103₹110.6 Cr

Mutual Funds

Domestic mutual funds & UTI

8.73%1 named
HolderStakeSharesValue (₹ Cr)
5.59%51,56,267₹564.1 Cr

DII (other)

Insurance, banks, AIF, other domestic institutions

6.68%No names

No named holders ≥1% in this bucket.

Super Investors

Curated tracked investor profiles

1.12%1 named
HolderStakeSharesValue (₹ Cr)
1.12%10,28,750₹112.6 Cr

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.